Universitätsklinikum Frankfurt am Main (KGU)

Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland (2025) Denk A, Fante MA, Heidenreich S, Greinix HT, Drouet EMW, Egger-Heidrich K, Marx J, et al. Journal article Prognostic value of CT-defined coronary sclerosis in COVID-19: Results of a multicenter study based on the Weston score (2025) Bucher AM, Frodl E, Ehrengut C, Müller L, Emrich T, Kloeckner R, Sieren M, et al. Journal article Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System—A Multicenter Cohort Study in 163 Patients (2025) Fisse AL, Bonberg N, Beuker C, Pfeuffer C, Heidenreich A, Krüger C, Deb-Chatterji M, et al. Journal article Relevance of instrumented gait analysis in the prediction of the rebound phenomenon after guided growth intervention (2024) Stief F, Holder J, Braun S, Brenneis M, van Drongelen S, Byrnes SK, Layher F, et al. Journal article On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer (2024) Sinn BV, Sychra K, Untch M, Karn T, van Mackelenbergh M, Huober J, Schmitt W, et al. Journal article Towards interactive AI-authoring with prototypical few-shot classifiers in histopathology (2024) Kuritcyn P, Kletzander R, Eisenberg S, Wittenberg T, Bruns V, Evert K, Keil F, et al. Journal article Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease (2024) Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching P, et al. Journal article Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy (2024) Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer (2024) Denkert C, Schneeweiss A, Rey J, Karn T, Hattesohl A, Weber KE, Rachakonda S, et al. Journal article